Pierschbacher M D, Ruoslahti E
Cancer Research Center, La Jolla Cancer Research Foundation, California 92037.
J Biol Chem. 1987 Dec 25;262(36):17294-8.
Peptides containing the tripeptide sequence Arg-Gly-Asp can duplicate or inhibit the cell attachment-promoting effects of fibronectin and vitronectin. Peptides analogous to a prototype peptide, Gly-Arg-Gly-Asp-Ser-Pro-Cys, the sequence of which was taken from the cell attachment site of fibronectin, were assayed for their relative abilities to inhibit the attachment of cells to a fibronectin or vitronectin substrate. A peptide having the L-Arg residue replaced with D-Arg showed no difference in this capacity, whereas substituting Gly with D-Ala or L-Asp with D-Asp resulted in completely inactive peptides. Replacement of L-Ser with D-Ser drastically reduced the influence that the resulting peptide had on the vitronectin interaction, but this peptide showed little difference in its effect on the binding of cells to fibronectin when compared with the prototype peptide. Furthermore, substitution of the Ser with L-Asn resulted in a peptide that had an apparent increased preference for the fibronectin receptor and decreased preference for the vitronectin receptor. Conversely, threonine in this position gave a peptide with increased preference for the vitronectin receptor, whereas L-Pro in this position gave a completely inactive peptide. Finally, by cyclicizing the prototype peptide to restrict its conformational flexibility, a peptide was obtained that was a much improved inhibitor of attachment of cells to vitronectin and yet nearly inactive with respect to the interactions of cells with fibronectin substrates. These studies lend support to the hypothesis that different Arg-Gly-Asp-directed adhesion receptors can recognize differences in the conformation and environment of the Arg-Gly-Asp tripeptide, and they establish the feasibility of obtaining synthetic probes that are more selective for individual receptors than are the peptides modeled after the natural sequences of adhesive extracellular matrix molecules.
含有三肽序列精氨酸-甘氨酸-天冬氨酸(Arg-Gly-Asp)的肽可以复制或抑制纤连蛋白和玻连蛋白促进细胞黏附的作用。对与一种原型肽(甘氨酸-精氨酸-甘氨酸-天冬氨酸-丝氨酸-脯氨酸-半胱氨酸,其序列取自纤连蛋白的细胞黏附位点)类似的肽,测定了它们抑制细胞黏附于纤连蛋白或玻连蛋白底物的相对能力。一种将L-精氨酸残基替换为D-精氨酸的肽在这种能力上没有差异,而将甘氨酸替换为D-丙氨酸或L-天冬氨酸替换为D-天冬氨酸则产生完全无活性的肽。将L-丝氨酸替换为D-丝氨酸极大地降低了所得肽对玻连蛋白相互作用的影响,但与原型肽相比,该肽对细胞与纤连蛋白结合的影响几乎没有差异。此外,将丝氨酸替换为L-天冬酰胺产生一种对纤连蛋白受体的偏好明显增加而对玻连蛋白受体的偏好降低的肽。相反,该位置的苏氨酸产生一种对玻连蛋白受体偏好增加的肽,而该位置的L-脯氨酸产生一种完全无活性的肽。最后,通过将原型肽环化以限制其构象灵活性,获得了一种肽,它是细胞黏附于玻连蛋白的更好的抑制剂,但对于细胞与纤连蛋白底物的相互作用几乎无活性。这些研究支持了这样的假说,即不同的由精氨酸-甘氨酸-天冬氨酸引导的黏附受体可以识别精氨酸-甘氨酸-天冬氨酸三肽的构象和环境差异,并且它们确立了获得比以细胞外基质黏附分子天然序列为模型的肽对单个受体更具选择性的合成探针的可行性。